Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 244-491-1 | CAS number: 21643-42-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Effects on fertility
Description of key information
In a well-conducted OECD TG 422 combined repeated dose and reproductive/developmental toxicity screening tests with the structural related 2-Propenoic acid, C12-14-alkyl esters (mixture of CAS no. 2156-97-0 and 21643-42-5) by oral gavage in rats no toxicity occurred up to the highest administered dose of 1000 mg/kg bw/day. The NOAEL was determined to 1000 mg/kg bw/day.
Based on these results the NOAEL of 2-Propenoic acid, tetradecyl ester is also considered to be 1000 mg/kg bw/day.
Effect on fertility: via oral route
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- NOAEL
- 1 000 mg/kg bw/day
- Study duration:
- subacute
- Species:
- rat
Effect on fertility: via inhalation route
- Endpoint conclusion:
- no study available
Effect on fertility: via dermal route
- Endpoint conclusion:
- no study available
Additional information
Combined Repeated Dose Toxicity Study with the Reproduction/Developmental Toxicity Screening Test (OECD 422) (Read across)
In a well performed OECD TG 422 / GLP study, 10 male and 10 female Wistar rats received the test item Laurylacrylate 1214 (read across approach) by daily oral gavage administration for 14 days before mating, through mating, gestation and the beginning of the lactation period (until day 4 post-partum, p.p.). The dose-levels were 100, 300 and 1000 mg/kg/day.
The study included check of clinical signs and mortality, body weight and food consumption, investigation of Functional Observation Battery; (FOB)) and motor activity, blood and urine analysis, macroscopic and microscopic examination, observation and examination of pups.
Regarding clinical examinations, nosigns of general systemic toxicity were observed in male or female parental animals of test groups 1-3 (100, 300 and 1000 mg/kg bw/d) during the entire study period.
Regarding fertility and reproductive performance, no signs of toxicity were observed in male or female parental animals of all test groups (100, 300 and 1000 mg/kg bw/d) during the entire study.
Regarding developmental toxicity, no biologically relevant signs of toxicity were observed in male or female pups of all test groups (100, 300 and 1000 mg/kg bw/d).
Regarding clinical pathology, no treatment-related, adverse effects were observed up to a dose of the compound of 1000 mg/kg bw/d.
Regarding pathology, the liver of male animals of test group 2 and 3 (300 and 1000 mg/kg bw/day, respectively) showed an increase in absolute (group 3 only) and relative weights which was regarded to be adaptive and non-adverse in the absence of histological findings.
All other findings recorded were considered to be incidental in nature and not related to treatment.
Thus, under the conditions of this reproduction/developmental toxicity screening test the NOAEL (no observed adverse effect level) for reproductive performance and fertility was 1000 mg/kg bw/d.
The NOAEL for developmental toxicity in the F1 progeny was found to be 1000 mg/kg bw/d.
The NOAEL for general, systemic toxicity was 1000 mg/kg bw/d.
Conclusion: Based on these results the NOAEL of 2 -Propenoic acid, tetradecyl ester is also considered to be 1000 mg/kg bw/day.
Effects on developmental toxicity
Description of key information
In a well-conducted OECD TG 422 combined repeated dose and reproductive/developmental toxicity screening tests with the structural analogue 2-Propenoic acid, C12-14-alkyl esters (mixture of CAS no. 2156-97-0 and 21643-42-5) by oral gavage in rats no toxicity occurred up to the highest administered dose of 1000 mg/kg bw/day. The NOAEL was determined to 1000 mg/kg bw/day.
Furthermore, in an experimental inhalation study with ethylhexyl acrylate comparable to OECD guideline 414, no developmental toxicity occured up to the highest dose of 100 ppm.
Based on these results the NOAEL of 2-Propenoic acid, tetradecyl ester is also considered to be 1000 mg/kg bw/day.
Effect on developmental toxicity: via oral route
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- NOAEL
- 1 000 mg/kg bw/day
- Study duration:
- subacute
- Species:
- rat
Effect on developmental toxicity: via inhalation route
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- NOAEC
- 750 mg/m³
- Study duration:
- subacute
- Species:
- rat
Effect on developmental toxicity: via dermal route
- Endpoint conclusion:
- no study available
Additional information
Combined Repeated Dose Toxicity Study with the Reproduction/Developmental Toxicity Screening Test (OECD 422) (Read across)
In a well performed OECD TG 422 / GLP study, 10 male and 10 female Wistar rats received the test item 2-Propenoic acid, C12-14-alkyl esters (mixture of CAS no. 2156-97-0 and 21643-42-5) (read across approach) by daily oral gavage administration for 14 days before mating, through mating, gestation and the beginning of the lactation period (until day 4 post-partum, p.p.). The dose-levels were 100, 300 and 1000 mg/kg/day.
The study included check of clinical signs and mortality, body weight and food consumption, investigation of Functional Observation Battery; (FOB)) and motor activity, blood and urine analysis, macroscopic and microscopic examination, observation and examination of pups.
Regardingclinical examinations, nosigns of general systemic toxicity were observed in male or female parental animals of test groups 1-3 (100, 300 and 1000 mg/kg bw/d) during the entire study period.
Regarding fertility and reproductive performance, no signs of toxicity were observed in male or female parental animals of all test groups (100, 300 and 1000 mg/kg bw/d) during the entire study.
Regarding developmental toxicity, no biologically relevant signs of toxicity were observed in male or female pups of all test groups (100, 300 and 1000 mg/kg bw/d).
Regarding clinical pathology, no treatment-related, adverse effects were observed up to a dose of the compound of 1000 mg/kg bw/d.
Regarding pathology, the liver of male animals of test group 2 and 3 (300 and 1000 mg/kg bw/day, respectively) showed an increase in absolute (group 3 only) and relative weights which was regarded to be adaptive and non-adverse in the absence of histological findings.
All other findings recorded were considered to be incidental in nature and not related to treatment.
Thus, under the conditions of this reproduction/developmental toxicity screening test the NOAEL (no observed adverse effect level) for reproductive performance and fertility was 1000 mg/kg bw/d.
The NOAEL for developmental toxicity in the F1 progeny was found to be 1000 mg/kg bw/d.
The NOAEL for general, systemic toxicity was 1000 mg/kg bw/d.
Saillenfait et al., 1999, (Read across)
2-EHA was investigated during a study on the relative developmental toxicities of a set of various acrylates (acrylic acid, methyl acrylate, butyl acrylate, hydroxyethyl acrylate, hydroxypropyl acrylate) in Sprague-Dawley rats. For the investigation with 2-EHA groups of 23 to 25 dams were exposed (6 hours/day, whole-body) to atmospheres containing 2-ethylhexyl acrylate (99.7 % purity) at 0, 50, 75, and 100 ppm (approximately 0.38, 0.56, and 0.75 mg/L) during day 6 to day 20 of gestation. Maternal food consumption was measured for the intervals of g.d. 6-13 and of g.d. 13-21. Maternal body weights were recorded on g.d . 0, 6, 13, and 2l. Dams were sacrificed on day 21 of gestation and the uteri were removed and weighed. The number of implantation sites, resorptions, and dead and live fetuses were recorded. Uteri, which had no visible implantation sites, were stained with ammonium sulfite (10 %) for the detection of early resorptions. At sacrifice live fetuses were weighed, sexed, and examined for external anomalies including those of the oral cavity. Half of live fetuses from each litter were examined for either internal soft tissue or for skeletal changes.
There were no maternal deaths in any of the treatment groups. Dams from the 100-ppm groups showed an absolute weight gain of 24±16 g through the period of exposure, which was lower and statistically significantly different from that of the concurrent control group (42 ± 11 g). Also food intake of 24 ± 3 g food/dam/day through the period of exposure of the 100-ppm group was somewhat lower and statistically significantly different in comparison to that of the concurrent control group (27 ± 2 g food/dam/day). No adverse effects were observed on the mean number of implantation sites per litter and on the mean number of live fetuses per litter in any of the 2-EHA exposed groups. The incidences of non-live implants (3.7 - 6.4 %) and of resorption sites per litter (3.7 - 6.1 %) in the treated groups were lower than those of the concurrent control (both 10.1 %). This observation, however, is not considered to be of toxicological significance. Mean fetal body weights were slightly lower in the treated groups, however not statistically significantly different from that of the concurrent control fetuses. Sex ratio was unaffected. No significant differences were observed between the control and the 2-EHA-treated groups in the incidences of gross anomalies or of visceral or skeletal malformations or variations.
In summary, no embryotoxic, teratogenic or fetotoxic properties of 2-EHA had been revealed from this study for concentrations of up to and including 100 ppm. Due to technical limitations exposure to higher concentrations could not be tested. Based on slightly reduced food intake and lower maternal weight gain at the higher exposure level a NOAEC for maternal toxicity of 75 ppm (approximately 0.56 mg/L) was derived from this study. No embryo-/fetotoxic effects were revealed even at the highest tested concentration at which some signs of maternal toxicity had been observed. Therefore, a NOAEC for developmental toxicity of 100 ppm (approximately 0.75 mg/L) was derived from this study.
Based on these results the NOAEL of 2 -Propenoic acid, tetradecyl ester is also considered to be 1000 mg/kg bw/day.
Justification for classification or non-classification
Classification, Labelling, and Packaging Regulation (EC) No. 1272/2008
The available screening studies are reliable and suitable for classification purposes under Regulation 1272/2008. As no substance-related adverse findings were noted up to the highest test dose, the substance is not considered to be classified for fertility or developmental toxicity under Regulation (EC) No. 1272/2008, as amended for the tenth time in Regulation (EC) No. 2017/776.
During the four days covered in the screening study, no effects via lactation were observed.
Additional information
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.